Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/26154

Title: Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine
Authors: Ratcliffe, Elizabeth
Thomas, Robert James
Williams, David J.
Keywords: Cell-based therapy
Regenerative medicine
Quality engineering
Cell culture automation
Issue Date: 2011
Publisher: Oxford University Press (© the author)
Citation: RATCLIFFE, E., THOMAS, R. and WILLIAMS, D., 2011. Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine. British Medical Bulletin, 100 (1), pp.137-155.
Abstract: BACKGROUND. A novel manufacturing industry is emerging to translate unique cellular therapy bioprocesses to robust, scaled manufacturing production for successful clinical translation. SOURCE OF DATA. This review summarizes key translational issues, and current and future perspectives to improve translation of cell-based therapy bioprocessing, based on literature search and author research. AREAS OF AGREEMENT. It is widely recognized that cell-based therapies could revolutionize health care for a range of diseases, and that there are gaps in the overarching framework and technologies to generate clinical success. AREAS OF CONTROVERSY. There is limited understanding of how to fulfil requirements as regulatory and manufacturing guidelines are incomplete and few have achieved commercialization. GROWING POINTS. Recent developments are encouraging adoption of automation and quality engineering approaches for bioprocessing of cell-based therapies. AREAS TIMELY FOR DEVELOPING RESEARCH. Include technology development to improve the cost and purity of manufacture and final product quality.
Sponsor: This work was supported by the UK Engineering and Physical Sciences Research Council-funded Centre for Innovative Manufacturing in Regenerative Medicine, which is a partnership of Loughborough, Nottingham and Keele Universities, and industry and the public sector stakeholders.
Version: Published
DOI: 10.1093/bmb/ldr037
URI: https://dspace.lboro.ac.uk/2134/26154
Publisher Link: http://dx.doi.org/10.1093/bmb/ldr037
ISSN: 0007-1420
Appears in Collections:Closed Access (Chemical Engineering)

Files associated with this item:

File Description SizeFormat
LDR037-corrected proof.pdfPublished version396.44 kBAdobe PDFView/Open


SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.